President & CEO

Co-founder and lead for PsychU (www.PsychU.org)

Rare Kidney Disease Community Members Join American Kidney Fund and IgA Nephropathy Foundation on Capitol Hill to Champion Key Legislation

Bipolar Disorder Market Research Report 2025-2035 | Pharma Leaders Advance Bipolar Disorder Treatment with Targeted Therapies and Genomic Innovation

Schizophrenia Market Research and Forecast Report 2025-2034 | Emerging Therapies and Genetic Research Drive Growth with Bristol Myers Squibb, AstraZeneca, and Eli Lilly Leading

Alzheimer’s Drugs Market to witness 20% CAGR due to increased diagnosis and drug innovation by 2029

Director, Health Technology Assessment (HTA) Lead

Otsuka Pharmaceutical Companies (U.S.) is seeking a Director, Health Technology Assessment (HTA) Lead to oversee the strategic development of HTA submissions. The role involves ensuring rigorous evidence generation activities to support global market access and reimbursement, while fostering partnerships with various teams for effective HTA and payer submissions.

TA Head, Neurology, Health Economics & Outcomes Research

Senior Health Science Manager

Senior Health Science Advisor , Player Coach Role: Manager and Individual Contributor

Senior Manager , Clinical Programming

Associate Director, Outcomes Research

Sign up with Google

Sign in with Google